Seroprevalence of Trypanosoma cruzi (TC) and risk factors in Colima, Mexico.
暂无分享,去创建一个
I. Delgado-Enciso | E. Dumonteil | B. Trujillo-Hernández | F. Espinoza-Gomez | Miriam de la Cruz-Ruiz | O. Newton-Sánchez | V. Melnikov | F. Rojas-Larios | Eric Dumonteil | Fabián Rojas-Larios
[1] M. Picollo,et al. Insecticide resistance in vector Chagas disease: evolution, mechanisms and management. , 2015, Acta tropica.
[2] L. Duarte,et al. Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in chronic phase of Chagas disease , 2014, Colombia medica.
[3] M. E. Berne,et al. Conventional serological performance in diagnosis of Chagas’ disease in southern Brazil , 2013, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[4] P. Hotez,et al. Bridging the innovation gap for neglected tropical diseases in México: capacity building for the development of a new generation of antipoverty vaccines , 2011 .
[5] David M. Frank,et al. Chagas Disease Risk in Texas , 2010, PLoS neglected tropical diseases.
[6] J. Muñoz,et al. Congenital transmission of Chagas disease: a clinical approach , 2010, Expert review of anti-infective therapy.
[7] S. Wendel. Transfusion transmitted Chagas disease: is it really under control? , 2010, Acta tropica.
[8] A. Silveira,et al. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. , 2009, Memorias do Instituto Oswaldo Cruz.
[9] P. Buekens,et al. Mother-to-Child Transmission of Chagas’ Disease in North America: Why Don’t We Do More? , 2008, Maternal and Child Health Journal.
[10] Alejandro Cruz-Reyes,et al. Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years--a review. , 2006, Memorias do Instituto Oswaldo Cruz.
[11] J M Ramsey,et al. Risk factors associated with house infestation by the Chagas disease vector Triatoma pallidipennis in Cuernavaca metropolitan area, Mexico , 2005, Medical and veterinary entomology.
[12] F. Espinoza-Gomez,et al. Active transmission of human chagas disease in Colima Mexico. , 2004, Memorias do Instituto Oswaldo Cruz.
[13] J. Dias,et al. The impact of Chagas disease control in Latin America: a review. , 2002, Memorias do Instituto Oswaldo Cruz.
[14] P. M. Schettino,et al. Iniciativa México: Propuesta para el control y vigilancia epidemiológica de la enfermedad de Chagas en México , 2001 .
[15] F. Zicker,et al. Evaluation of risk factors for house infestation by Triatoma infestans in Brazil. , 1995, The American journal of tropical medicine and hygiene.
[16] M. L. Belaunzarán. [Chagas disease: Globalization and new hope for its cure]. , 2015, Revista Argentina de microbiologia.
[17] J. C. Vazquez-Chagoyán,et al. Risk factors associated with triatomines and its infection with Trypanosoma cruzi in rural communities from the southern region of the State of Mexico, Mexico. , 2010, The American journal of tropical medicine and hygiene.
[18] R. Tapia,et al. [Seroprevalence of Trypanosoma cruzi antibodies and associated risk factors among the population under 18 years of age in Veracruz, Mexico]. , 2007, Revista panamericana de salud publica = Pan American journal of public health.
[19] P. Reyes,et al. Factores bióticos y abióticos que determinan la seroprevalencia de anticuerpos contra Trypanosoma Cruzi en el municipio de Palmar de Bravo, Puebla, México , 2004 .
[20] Por Vector. NORMA Oficial Mexicana NOM-032-SSA2-2002, Para la vigilancia epidemiológica, prevención y control de enfermedades transmitidas por vector. , 2002 .
[21] I. Fernández-Salas,et al. Presence of triatominae (Hemiptera, Reduviidae) and risk of transmission of Chagas disease in Colima, México. , 2002, Memorias do Instituto Oswaldo Cruz.
[22] J. Blejer,et al. [Prevalence of Trypanosoma cruzi antibodies in blood donors]. , 1999, Medicina.
[23] C. Schofield. A comparison of sampling techniques for domestic populations of Triatominae. , 1978, Transactions of the Royal Society of Tropical Medicine and Hygiene.